BRUKER CORP. news, videos and press releases - Page 2
For more news please use our advanced search feature.
BRUKER CORP. - More news...
BRUKER CORP. - More news...
- Bruker Introduces New Mycobacteria and Fungi IVD Solutions for MALDI Biotyper®, and a Novel LiquidArray® Gastrointestinal Syndromic Panel
- PreOmics Introduces a Novel BeatBox™ FFPE Workflow for Accelerated, In-depth Tissue Proteomics
- Canopy Biosciences and Enable Medicine Announce Partnership to Bring Advanced Spatial Analysis Pipelines to the ChipCytometry Platform
- Bruker Announces Two 1.2 GHz NMR Systems Orders from the UK
- Bruker Launches de novo Sequencing for Immunopeptidomics, Library-Free dia-PASEF, Mass Dynamics Knowledge Visualization
- Bruker Corporation to Present at Investor Conferences
- Bruker Announces Quarterly Dividend
- Bruker Reports Fourth Quarter and Fiscal Year 2022 Financial Results
- Bruker Announces Successful Customer Installations of First Two Compact 1.0 GHz NMR Systems to Advance Structural Biology
- Bruker Announces Date and Time of Fourth Quarter 2022 Earnings Release and Webcast
- Bruker Announces Acquisition of ACQUIFER Imaging GmbH
- Biognosys and Bruker Form Partnership for Advanced Proteomics CRO Services for Global Biopharma and Biomarker Customers
- Bruker Corporation to Present at the 41st Annual J.P. Morgan Healthcare Conference
- Bruker Energy & Supercon Technologies (BEST) Announces Multi-Year Orders for Key Magnetic Confinement Fusion Technologies
- Bruker Announces Agreement to Acquire Neurescence Inc., Bolstering Neuroscience Research Portfolio
- Bruker Announces Quarterly Dividend
- Bruker Announces Acquisition of Inscopix for Neuroscience Research
- Bruker Corporation to Participate in the 2022 Jefferies London Healthcare Conference
- Bruker Reports Third Quarter 2022 Financial Results
- Bruker Announces Date and Time of Third Quarter 2022 Earnings Release and Webcast
- Bruker Launches New nanoElute® 2 nano-LC For 4D-Proteomics, Advances Fluxomics Applications with MetaboScape® 2023 Software
- Bruker Introduces Enabling New Scientific Capabilities for Cell Biology and Pathobiology Research with High-Field NMR Innovations
- Bruker Announces Quarterly Dividend
- Bruker Reports Second Quarter 2022 Financial Results
- Bruker Announces Date and Time of Second Quarter 2022 Earnings Release and Webcast
- Bruker Announces Three New GHz NMR Systems Orders for Functional Structural Biology and Clinical Phenomics Research
- Bruker Launches NMR-based Molecular Phenomics Clinical Research Tool for ‘Long COVID’ Multi-Organ Risk Assessment
- Bruker is Ushering in the Age of Spatial Single-Cell Metabolomics
- Bruker Introduces Enhanced 3D Holographic Stimulation for Optogenetics on its Ultima 2Pplus Multiphoton Microscope
- Bruker Announces Key Innovations for Highly Multiplexed Spatial Proteomics and Multiomic Tissue Imaging at Large Field-of-View
